The Growing Need for Drug-Price Transparency

More and more states are considering laws that would require drug companies and insurance companies to provide more transparency in the cost and coverage of some prescription drugs.

This article discusses the increasing legislation many states are passing to hold the pharmaceutical and insurance companies accountable for drug pricing.

To view this article, click the following link to access the original content.